Transhepatic CT-guided radiofrequency ablation of adrenal metastases from hepatocellular carcinoma.
The prognosis of patients with adrenal metastases from hepatocellular carcinoma (HCC) has been poor, and aggressive treatment of these tumors is mandatory to improve patients' survival. Since adrenalectomy may be difficult to perform after previous surgery of the right liver lobe, other approaches are required to treat the adrenal mass. This report aims at demonstrating the feasibility of CT-guided transhepatic radiofrequency ablation of right adrenal HCC metastases pretreated with chemoembolization in patients unable to undergo surgical resection.
Kuehl
Hilmar
H
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University at Duisburg-Essen, Hufelandstr 55, 45122 Essen, Germany. hilmar.kuehl@uni-due.de
Stattaus
Joerg
J
Forsting
Michael
M
Antoch
Gerald
G
D000310:Adrenal Gland Neoplasms / Q000556:secondary / Q000601:surgery*; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000556:secondary / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods*; D003287:Contrast Media; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology*; D053783:Magnetic Resonance Imaging, Interventional; D008297:Male; D015641:Radiography, Interventional; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D003287:Contrast Media